ClientsBiotechnology Companies
Start-up Companies Universities Consultant Subcontracting Not-for-profit Societies Private Research Institutions Testimonials "The drug development business plan provided by SoMax Consulting exceeded my expectations. Dr. Elizabeth Smith captured the essence of my business idea perfectly, and was very knowledgeable of the pharmaceutical business and regulatory environment. The response time was great, and the final document was exceedingly thorough and professionally done. I enthusiastically recommend SoMax Consulting and fully believe that they are capable of handling any kind of business planning with thoughtfulness, maturity, professionalism, and a real desire to help". -Dr. Erik Lillhoj, U. Maryland School of Medicine Dr. Smith, I am writing to let you know how helpful we found the commercialization plan you created for our drug candidate. The format was extremely well organized around the big picture of our project. At the same time, it was so thorough and detail oriented. I especially appreciate the time you took to interview the founders and customize the plan based on our feedback and concerns. It would have taken our group many, many hours, if not years, to assemble all this valuable information on our own. Your recommendations for attorneys, consultants, regulatory experts, CDMOs and funding sources will be a great resource too. I wanted to genuinely thank you for your outstanding work. Sincerely, Simeon E. Goldblum, M.D. Professor of Medicine University of Maryland School of Medicine "Elizabeth prepared a commercialization plan for the use of a small molecule for the treatment of Alzheimer’s Disease and of AIDS. During the four months she steadily worked on the commercialization plan, she communicated often to make sure the plan was in line with what was expected. Elizabeth is flexible, reliable, and her work is thorough and comprehensive. It has been a pleasure to work with Elizabeth and I recommend her without reservations." -Camilo Rojas, Ph.D. Johns Hopkins School of Medicine |
ProjectsTherapeutics
Lentivirus Gene Therapy, Metabolic disease Molecule for the Treatment of Idiopathic Pulmonary Fibrosis Lentiviral Autologous Cell Therapy, Solid Tumors Prophylactic for Liver Stage Malaria NCE Rx for Triple Negative BC mAb Rx with oral yeast delivery system Biologic for metastatic CRPC Small Molecule for Myc Suppression Anti-Tag Chimeric Antigen Receptor (AT-CAR) T-Cell Therapy Small Molecule Inhibitor of P53 for Ischemia Novel Class of Gram-Negative Antibiotics microRNA for multi-oncogene suppression Biologic for Pseudonomas VAP Antibody decorated nanoparticle for cancer immunotherapy Diagnostics IR for Identification of Bacterial Species Detection of Alt Using qPCR for Cancer Quantitation of NKT by qPCR for Cancer or AI Devices High Intensity Focused Ultrasound Blood Oxygenator, Mobile Waist-pack. Nanoparticle Drug Delivery to Dentin Regenerative Joint Replacement Emergency O2 Delivery for Obstructed Windpipe Platform Technologies 3D "micro-organs" on a chip for HTS Algal Expression System Lamprey Antibodies Controlled Glycosylation System Biosimilar Expression System Joint Targeting Peptides for Rheumatoid Arthritis Novel Bacterial Induction System for Mfg. Scale Hyper-glycosylation of Ab Fc Regions to Improved Efficacy NMR Technology for Detecting Biopharmaceutical Aggregation |
